Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]        
Revenues
Operating Expenses        
Research and development 1,551,341 2,015,940 7,742,520 4,680,486
General and administrative 2,293,517 2,258,322 3,982,181 3,821,317
Stock-based compensation – general and administrative 342,962 158,833 619,544 379,217
Total Operating Expenses 4,187,820 4,433,095 12,344,245 8,881,020
Operating Loss (4,187,820) (4,433,095) (12,344,245) (8,881,020)
Other Income (Expense)        
Other income 110,207
Interest income 69,327 12,106 82,811 31,445
Interest expense (3,939) (3,980) (7,907) (7,971)
Total Other Income, Net 65,388 8,126 74,904 133,681
Net Loss $ (4,122,432) $ (4,424,969) $ (12,269,341) $ (8,747,339)
Net Loss Per Share - Basic and Diluted $ (0.04) $ (0.13) $ (0.16) $ (0.28)
Weighted Average Common Shares Outstanding        
Basic and diluted 95,997,427 34,318,761 75,565,121 31,744,379